You are here

Perceived Barriers to Using rTMS for depression: A National Survey of Psychiatrists, Patients, Caregivers, and the General Public

Scheduled Maintenance Notice: clinicaltmssociety.org is scheduled to undergo maintenance on Monday, March 27th starting at 9am and ending at 3pm (PDT). The website will be inaccessible during the maintenance window. If you have any questions, please contact us at info@clinicaltmssociety.org.

×

Warning message

This webinar is restricted to registered participants or on-demand registrants. Click the following link to register: Register Here

Perceived Barriers to Using rTMS for depression: A National Survey of Psychiatrists, Patients, Caregivers, and the General Public - Grand Rounds Webinar

You’re invited to join the Clinical TMS Society for this installment of our Grand Round Webinar Series: Perceived Barriers to Using rTMS for depression: A National Survey of Psychiatrists, Patients, Caregivers, and the General Public.

Don't miss out on our Q&A portion of the webinar!

At the end of this presentation participants will be able to:

  1. Recognize differences in perceived barriers to using rTMS by different stakeholder groups

  2. Describe key perceived barriers to using rTMS for depression

  3. Understand how patient and clinician sociodemographic characteristics shape perceived barriers to TMS

Format: On-Demand

Cost: Members: $25 | Non-members $50 | Student Members FREE


SPEAKERS:

Laura Cabrera, PhD

Dr. Cabrera is the Dorothy Foehr Huck and J. Lloyd Huck Chair in Neuroethics. She is an Associate Professor of Engineering Science and Mechanics, and Philosophy at Penn State University. She is a Research Associate at the Rock Ethics Institute, and affiliated with the Center for Neural Engineering. She is also Faculty Affiliate at Neuroethics Canada, University of British Columbia. She received a BEng in Electrical and Communication Engineering from the Instituto Tecnológico de Estudios Superiores de Monterrey (ITESM) in Mexico City, an MA in Applied Ethics from Linköping University in Sweden, and a PhD in Applied Ethics from Charles Sturt University in Australia. 

Dr. Cabrera's interests focus on the ethical and societal implications of neurotechnologies used for health and medicine, as well as for non-medical purposes. She has been working on projects at the interface of normative, conceptual and empirical approaches, exploring attitudes and ethical concerns of professionals, patients and members of the public toward brain interventions. Her work has also focused on the ethical and social implications of environmental changes for brain and mental health.  Her current work focuses on the responsible use of psychiatric electroceutical interventions, and the timing of deep brain stimulation for Parkinson’s Disease.

Dr. Cabrera is an honorific member of the Mexican Neuroethics Society, chair of the IEEE Brain Neuroethics Subcommittee, and member of the International Neuroethics Society (INS) Board of Directors. Her career goal is to pursue interdisciplinary neuroethics scholarship, provide active leadership, and train and mentor future leaders in the field.


 

Vertical Tabs

Vertical Tabs

ENDURING MATERIAL LEARNER NOTIFICATION

Clinical TMS Society
Grand Round Perceived Barriers to Using rTMS for depression: A National Survey of Psychiatrists, Patients, Caregivers, and the General Public Enduring Material

Date of CE Expiration:  April 7, 2024

Location: Online

 Acknowledgement of Financial and/in In-Kind Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Satisfactory Completion 

Learners must listen to each self-directed audio recording while following along with the visual slides and complete an evaluation form to receive a certificate of completion. You must take in the entire activity as partial credit is not available.  

If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.  

 Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Clinical TMS Society.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 Physicians (ACCME) Credit Designation

Amedco LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives - After Attending This Program You Should Be Able To
  1. Recognize differences in perceived barriers to using rTMS by different stakeholder groups
  2. Describe key perceived barriers to using rTMS for depression
  3. Explain how patient and clinician sociodemographic characteristics shape perceived barriers to TMS

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest, and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

First Name

Last Name

Commercial Interest:Relationship

Laura

Cabrera

NA

Sheryl

Morgan

NA

Randall

Van Ornam

NA

Saydra

Wilson

University of Minnesota:Employee* / MnDRIVE Brain conditions:Research Grant Overall Principal Investigator / Clinical TMS Society PULSES lecturer:Other / Neurolief MOOD study:Other

* Disclosure was reviewed and determined that no conflict exists